Saved in:
| Main Authors: | Rajib Dhar, Arikketh Devi |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1002/ctd2.320 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Milk exosomes: Harnessing nature's duality for cancer therapy
by: Asmit Das, et al.
Published: (2024)
by: Asmit Das, et al.
Published: (2024)
Tumor and cancer stem cells‐derived exosomes interplay: A secret of cancer complications
by: Swarup Sonar, et al.
Published: (2024)
by: Swarup Sonar, et al.
Published: (2024)
Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
by: Swastika Maitra, et al.
Published: (2024)
by: Swastika Maitra, et al.
Published: (2024)
Clinical signature of exosomal tetraspanin proteins in cancer
by: Asmit Das, et al.
Published: (2024)
by: Asmit Das, et al.
Published: (2024)
The prospective trajectory of exosomes‐based cancer nanomedicine
by: Divya Mirgh, et al.
Published: (2024)
by: Divya Mirgh, et al.
Published: (2024)
Clinical trial status of exosomes‐based cancer theranostics
by: Swarup Sonar
Published: (2024)
by: Swarup Sonar
Published: (2024)
Signature of click chemistry in exosome modification for cancer therapeutic
by: Nobendu Mukerjee, et al.
Published: (2024)
by: Nobendu Mukerjee, et al.
Published: (2024)
Plant exosomes: A natural medicine for oral cancer
by: Sidhanti Nyahatkar, et al.
Published: (2024)
by: Sidhanti Nyahatkar, et al.
Published: (2024)
Modified plant‐derived exosomes: Precision medicine in cancer treatment
by: Swastika Maitra, et al.
Published: (2024)
by: Swastika Maitra, et al.
Published: (2024)
Sweat exosomes: A new cutting edge nanomedicine in cancer treatment
by: Bikram Dhara, et al.
Published: (2024)
by: Bikram Dhara, et al.
Published: (2024)
Plant‐derived exosomes: A Green Nanomedicine for Cancer
by: Swarup Sonar, et al.
Published: (2024)
by: Swarup Sonar, et al.
Published: (2024)
scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
by: Fansen Ji, et al.
Published: (2025)
by: Fansen Ji, et al.
Published: (2025)
Effects of microRNA on the growth and targeted therapy response on lung cancer
by: Mengchen Zhu, et al.
Published: (2024)
by: Mengchen Zhu, et al.
Published: (2024)
Liquid biopsy—A biomarker‐based revolutionising technique in cancer therapy
by: Subham Sarkar, et al.
Published: (2024)
by: Subham Sarkar, et al.
Published: (2024)
Mesenchymal stem cell therapy for ulcerative colitis: Opportunities and challenges in precision medicine
by: Peng‐Fei Wang, et al.
Published: (2025)
by: Peng‐Fei Wang, et al.
Published: (2025)
Bacterial surface derived extracellular vesicles: A ground‐breaking approach in cancer therapy
by: Asmit Das, et al.
Published: (2024)
by: Asmit Das, et al.
Published: (2024)
Sculpting nursing resilience: Transforming lives, nurturing ethics in chimeric antigen receptor T‐cell therapy
by: Pranay Bende
Published: (2024)
by: Pranay Bende
Published: (2024)
Translational values of tissue‐resident memory T cells in chronic inflammation and cancer
by: Wanxin Duan, et al.
Published: (2025)
by: Wanxin Duan, et al.
Published: (2025)
Host–microbiota interaction during cancer progression from bulk to single‐cell level
by: Yong‐Jing Ma, et al.
Published: (2024)
by: Yong‐Jing Ma, et al.
Published: (2024)
Single‐cell sequencing for cancer precision medicine: From mechanism discovery to diagnosis and therapeutics
by: Yue Zhao, et al.
Published: (2026)
by: Yue Zhao, et al.
Published: (2026)
Anti‐PF4 antibody inhibit proliferation of lung cancer cells without TP53 mutation by inducing apoptosis and cell cycle arrest
by: Mengjia Qian, et al.
Published: (2025)
by: Mengjia Qian, et al.
Published: (2025)
Gastric cancer detection based on cell‐free DNA in blood: A systematic review and meta‐analysis
by: Mona Wang, et al.
Published: (2024)
by: Mona Wang, et al.
Published: (2024)
Inflammatory‐associated myeloid dendritic cells reveals associations between chronic lung diseases and lung cancer
by: Zhiyu Chen, et al.
Published: (2024)
by: Zhiyu Chen, et al.
Published: (2024)
Challenges and advances of immune checkpoint therapy
by: Lingyu Li, et al.
Published: (2024)
by: Lingyu Li, et al.
Published: (2024)
Tumour hepcidin levels as a biomarker for predicting response to immune checkpoint inhibition in advanced non‐small cell lung cancer
by: Yuichiro Suzukawa, et al.
Published: (2026)
by: Yuichiro Suzukawa, et al.
Published: (2026)
Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
by: Xinni Chen, et al.
Published: (2026)
by: Xinni Chen, et al.
Published: (2026)
Targeting mutated KRAS in the first‐line therapy
by: Hideaki Ijichi
Published: (2024)
by: Hideaki Ijichi
Published: (2024)
Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies
by: Yushan Huang, et al.
Published: (2026)
by: Yushan Huang, et al.
Published: (2026)
EccDNA, STING activation, and their potential roles in DLBCL prognosis and therapy
by: Xi‐Bo Hu, et al.
Published: (2024)
by: Xi‐Bo Hu, et al.
Published: (2024)
Spatial omics accelerate the study of cancer‐associated fibroblasts in non‐small lung cancer
by: Haozhen Liu, et al.
Published: (2024)
by: Haozhen Liu, et al.
Published: (2024)
Single‐cell and spatial alterations of neural cells and circuits in clinical and translational medicine
by: William Wang, et al.
Published: (2024)
by: William Wang, et al.
Published: (2024)
Clinical and translational mode of single‐cell measurements: An artificial intelligent single cell
by: Xiangdong Wang, et al.
Published: (2024)
by: Xiangdong Wang, et al.
Published: (2024)
Roles of telocytes dominated cell–cell communication in fibroproliferative acute respiratory distress syndrome
by: Yonghua Zheng, et al.
Published: (2024)
by: Yonghua Zheng, et al.
Published: (2024)
CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
by: Dongchun Xie, et al.
Published: (2024)
by: Dongchun Xie, et al.
Published: (2024)
Exploring new frontiers in lung cancer treatment: The role of cancer‐associated fibroblasts (CAFs) and EGFR‐TKI resistance
by: Jiaqi Liang, et al.
Published: (2025)
by: Jiaqi Liang, et al.
Published: (2025)
Investigating the biological effects of socioeconomic adversity in cancer
by: David Füller
Published: (2024)
by: David Füller
Published: (2024)
Nanomedicine: a frontier of the breast cancer treatment
by: Swarup Sonar, et al.
Published: (2024)
by: Swarup Sonar, et al.
Published: (2024)
The role of T cells in sepsis of distinct infectious aetiologies
by: Xuanqi Liu, et al.
Published: (2026)
by: Xuanqi Liu, et al.
Published: (2026)
Significance of stereologically spatiotemporal cells in molecular medicine
by: Xuanqi Liu, et al.
Published: (2025)
by: Xuanqi Liu, et al.
Published: (2025)
The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy
by: Jing Zhao, et al.
Published: (2025)
by: Jing Zhao, et al.
Published: (2025)
Similar Items
-
Milk exosomes: Harnessing nature's duality for cancer therapy
by: Asmit Das, et al.
Published: (2024) -
Tumor and cancer stem cells‐derived exosomes interplay: A secret of cancer complications
by: Swarup Sonar, et al.
Published: (2024) -
Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
by: Swastika Maitra, et al.
Published: (2024) -
Clinical signature of exosomal tetraspanin proteins in cancer
by: Asmit Das, et al.
Published: (2024) -
The prospective trajectory of exosomes‐based cancer nanomedicine
by: Divya Mirgh, et al.
Published: (2024)